Platinum drugs in the treatment of non-small-cell lung cancer

por Cosaert, J, Quoix, E
Publicado 2002

Quality Improvement Guidelines for Bone Tumour Management

por Gangi, A., Tsoumakidou, G., Buy, X., Quoix, E.
Publicado 2010

Non-small-cell lung cancer in a French department, (1982–1997): management and outcome

por Foeglé, J, Hédelin, G, Lebitasy, M P, Purohit, A, Velten, M, Quoix, E
Publicado 2005

Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994

por Lebitasy, M P, Hédelin, G, Purohit, A, Moreau, L, Klinzig, F, Quoix, E
Publicado 2001

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

por Jacot, W, Quantin, X, Boher, J-M, Andre, F, Moreau, L, Gainet, M, Depierre, A, Quoix, E, Chevalier, T Le, Pujol, J-L
Publicado 2001

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

por Beau-Faller, M, Legrain, M, Voegeli, A-C, Guérin, E, Lavaux, T, Ruppert, A-M, Neuville, A, Massard, G, Wihlm, J-M, Quoix, E, Oudet, P, Gaub, M P
Publicado 2009

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado 2004

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

por McKeage, M J, Von Pawel, J, Reck, M, Jameson, M B, Rosenthal, M A, Sullivan, R, Gibbs, D, Mainwaring, P N, Serke, M, Lafitte, J-J, Chouaid, C, Freitag, L, Quoix, E
Publicado 2008

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 rando...

por Giaccone, G., Felip, E., Cobo, M., Campelo, R. Garcia, DENIS, F., Quoix, E., Madroszyk, A., Debieuvre, D., Hilgers, W., Moran, T., Galetta, D., Romano, G.D., Cappuzzo, F., Robinet, G., Masson, P., Viteri, S., Peled, N., Costantini, D., Dziadziuszko, R., Besse, B.
Publicado 2020

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

por Molinier, O., Besse, B., Barlesi, F., Audigier-Valette, C., Friard, S., Monnet, I., Jeannin, G., Mazières, J., Cadranel, J., Hureaux, J., Hilgers, W., Quoix, E., Coudert, B., Moro-Sibilot, D., Fauchon, E., Westeel, V., Brun, P., Langlais, A., Morin, F., Souquet, P.J., Girard, N.
Publicado 2021

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of...

por Couraud, S., Cortot, A. B., Greillier, L., Gounant, V., Mennecier, B., Girard, N., Besse, B., Brouchet, L., Castelnau, O., Frappé, P., Ferretti, G. R., Guittet, L., Khalil, A., Lefebure, P., Laurent, F., Liebart, S., Molinier, O., Quoix, E., Revel, M.-P., Stach, B., Souquet, P.-J., Thomas, P., Trédaniel, J., Lemarié, E., Zalcman, G., Barlési, F., Milleron, B.
Publicado 2013

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

por Depierre, A, Lagrange, J L, Theobald, S, Astoul, P, Baldeyrou, P, Bardet, E, Bazelly, B, Bréchot, J M, Breton, J L, Douillard, J Y, Grivaux, M, Jacoulet, P, Khalil, A, Lemarié, E, Martinet, Y, Massard, G, Milleron, B, Molina, T, Moro-Sibilot, D, Paesmans, M, Pujol, J L, Quoix, E, Ranfaing, E, Rivière, A, Sancho-Garnier, H, Souquet, P J, Spaeth, D, Stœbner-Delbarre, A, Thiberville, L, Touboul, E, Vaylet, F, Vergnon, J M, Westeel, V
Publicado 2003